Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Aldeyra Therapeutics, Inc.
Lexington, Massachusetts
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement onForm S-3 of our report dated March 29, 2018 relating to the financial statements of Aldeyra Therapeutics, Inc. appearing in the Company’s Annual Report on Form10-K for the year ended December 31, 2017.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP |
Boston, Massachusetts |
July 18, 2018 |
